Special Edition: Compounding Concerns—Diabetes and Obesity Medications
“Compounding Concerns: Diabetes and Obesity Medications” is the first of four series comprising Diabetes Core Update’s 12-episode “Elevating Diabetes Care: Advanced Clinical Insights” program.
This 3-episode series and the “Elevating Diabetes Care: Advanced Clinical Insights Program” are supported by Lilly.
This three-episode mini-series of Diabetes Core Update is part of a 12-episode partnership with Lilly, spotlighting critical topics in diabetes care. This mini-series focuses on compounded medications used to treat diabetes and/or obesity. The first episode examines regulatory, safety, and supply considerations for compounded medications, comparing them to FDA-approved and commercially manufactured products. The second episode explores the risks versus benefits of compounded treatments, offering case-based insights from clinicians and pharmacists. The final episode, tailored for patients, simplifies the discussion to empower individuals with diabetes to make informed decisions in partnership with their doctors.
The views, thoughts, and opinions expressed in this podcast belong solely to the individual speakers and do not necessarily reflect the views or opinions of Eli Lilly and Company or any of its affiliates.
Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform.
December 27, 2024
Special Edition: Understanding Compounded Medications in Diabetes Care
Play Episode
Total Time: 38:35 | File Size: 53.3 MB
Episode Notes
In this special edition of Diabetes Core Update, host Neil Skolnik, MD, explores the timely and critical topic of compounded medications in diabetes care. Dr. Skolnik is joined by John Hertig, PharmD, MS, CPPS, Associate Professor at the Butler University College of Pharmacy and Health Sciences, and Ed Hernandez, Executive Vice President and President of Manufacturing Operations at Eli Lilly & Company.
Together, they discuss the role of compounded medications, the benefits and risks associated with their use, and the importance of ensuring quality and safety standards in the compounding process. This episode offers valuable insights for clinicians navigating the complexities of compounded therapies and provides practical considerations for patient care.
“Compounding Concerns: Diabetes and Obesity Medications” is the first of four series comprising Diabetes Core Update’s 12-episode “Elevating Diabetes Care: Advanced Clinical Insights” program.
This 3-episode series and the “Elevating Diabetes Care: Advanced Clinical Insights Program” are supported by Lilly.
The views, thoughts, and opinions expressed in this podcast belong solely to the individual speakers and do not necessarily reflect the views or opinions of Eli Lilly and Company or any of its affiliates.
Presented by:
Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
John Hertig, PharmD, MS, CPPS, Associate Professor, Butler University College of Pharmacy and Health Sciences
Ed Hernandez, Executive Vice President, Eli Lilly & Company; President of Manufacturing Operations at Lilly
Thank you for listening to this special edition of Diabetes Core Update. Stay safe and keep learning!
Selected References:
Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association. Diabetes Care December 2, 2024; https://doi.org/10.2337/dci24-0091 PubMed: 39620926
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. US FDA Website (current as of 12/18/2024)
Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from ADA’s four scholarly journals: Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Users can freely access previous episodes of Diabetes Core Update here.
For previous episodes, please visit:
